{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:05:20Z","timestamp":1782925520582,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,8,19]],"date-time":"2012-08-19T00:00:00Z","timestamp":1345334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10549-012-2198-y","type":"journal-article","created":{"date-parts":[[2012,8,18]],"date-time":"2012-08-18T05:08:00Z","timestamp":1345266480000},"page":"603-609","source":"Crossref","is-referenced-by-count":147,"title":["Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case\u2013control study"],"prefix":"10.1007","volume":"135","author":[{"given":"Isabelle","family":"Le Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dell\u2019Aniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bonnetain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Suissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,19]]},"reference":[{"key":"2198_CR1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687\u20131717","journal-title":"Lancet"},{"issue":"Suppl 8","key":"2198_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/annonc\/mdm263","volume":"18","author":"EA Perez","year":"2007","unstructured":"Perez EA (2007) Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer. Ann Oncol 18(Suppl 8):26\u201335","journal-title":"Ann Oncol"},{"key":"2198_CR3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.steroids.2007.07.009","volume":"72","author":"VC Jordan","year":"2007","unstructured":"Jordan VC (2007) New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer. Steroids 72:829\u2013842","journal-title":"Steroids"},{"key":"2198_CR4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3816\/CBC.2009.n.020","volume":"9","author":"SN Chin","year":"2009","unstructured":"Chin SN, Trinkaus M, Simmons C, Flynn C, Dranitsaris G, Bolivar R, Clemons M (2009) Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer. Clin Breast Cancer 9:108\u2013117","journal-title":"Clin Breast Cancer"},{"key":"2198_CR5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.breast.2008.04.001","volume":"17","author":"K Mok","year":"2008","unstructured":"Mok K, Juraskova I, Friedlander M (2008) The impact of aromatase inhibitors on sexual functioning: current knowledge and future research directions. Breast 17:436\u2013440","journal-title":"Breast"},{"issue":"26","key":"2198_CR6","first-page":"e1","volume":"204","author":"J Baumgart","year":"2011","unstructured":"Baumgart J, Nilsson K, Stavreus-Evers A, Kask K, Villman K, Lindman H, Kallak T, Sundstr\u00f6m-Poromaa I (2011) Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. Am J Obstet Gynecol 204(26):e1\u20137","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"2198_CR7","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.3747\/co.2007.151","volume":"14","author":"C Derzko","year":"2007","unstructured":"Derzko C, Elliott S, Lam W (2007) Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol 14(Suppl 1):S20\u201340","journal-title":"Curr Oncol"},{"key":"2198_CR8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","volume":"17","author":"A Kendall","year":"2006","unstructured":"Kendall A (2006) Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 17:584\u2013587","journal-title":"Ann Oncol"},{"key":"2198_CR9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(97)04248-7","volume":"350","author":"T Walley","year":"1997","unstructured":"Walley T, Mantgani A (1997) The UK General Practice Research Database. Lancet 350:1097\u20131099","journal-title":"Lancet"},{"key":"2198_CR10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2125.1998.00701.x","volume":"45","author":"LA Garc\u00eda Rodr\u00edguez","year":"1998","unstructured":"Garc\u00eda Rodr\u00edguez LA, P\u00e9rez Gutthann S (1998) Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 45:419\u2013425","journal-title":"Br J Clin Pharmacol"},{"key":"2198_CR11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/bmj.302.6779.766","volume":"302","author":"H Jick","year":"1991","unstructured":"Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J 302:766\u2013768","journal-title":"Br Med J"},{"key":"2198_CR12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/pubmed\/21.3.299","volume":"21","author":"R Lawrenson","year":"1999","unstructured":"Lawrenson R, Williams T, Farmer R (1999) Clinical information for research; the use of general practice databases. J Public Health Med 21:299\u2013304","journal-title":"J Public Health Med"},{"key":"2198_CR13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1592\/phco.23.5.686.32205","volume":"23","author":"SS Jick","year":"2003","unstructured":"Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodr\u00edguez LA, Ruig\u00f3mez A, Meier CR, Schlienger RG, Black C, Jick H (2003) Validity of the general practice research database. Pharmacotherapy 23:686\u2013689","journal-title":"Pharmacotherapy"},{"key":"2198_CR14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-2125.2000.00199.x","volume":"49","author":"R Lawrenson","year":"2000","unstructured":"Lawrenson R, Todd JC, Leydon GM, Williams TJ, Farmer RD (2000) Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol 49:591\u2013596","journal-title":"Br J Clin Pharmacol"},{"key":"2198_CR15","first-page":"811","volume-title":"Pharmacoepidemiology","author":"S Suissa","year":"2005","unstructured":"Suissa S (2005) Novel approaches to pharmacoepidemiology study design and statistical analysis. In: Dans Strom B (ed) Pharmacoepidemiology, 4th edn. Wiley, Chichester, pp 811\u2013829","edition":"4"},{"key":"2198_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-5-5","volume":"5","author":"V Essebag","year":"2005","unstructured":"Essebag V, Platt RW, Abrahamowicz M, Pilote L (2005) Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol 5:5","journal-title":"BMC Med Res Methodol"},{"key":"2198_CR17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0002-8703(03)00512-X","volume":"146","author":"V Essebag","year":"2003","unstructured":"Essebag V, Genest J Jr, Suissa S, Pilote L (2003) The nested case\u2013control study in cardiology. Am Heart J 146:581\u2013590","journal-title":"Am Heart J"},{"key":"2198_CR18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10549-010-1162-y","volume":"126","author":"L Azoulay","year":"2011","unstructured":"Azoulay L, Dell\u2019Aniello S, Huiart L, du Fort GG, Suissa S (2011) Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence. Breast Cancer Res Treat 126:695\u2013703","journal-title":"Breast Cancer Res Treat"},{"key":"2198_CR19","first-page":"812","volume":"48","author":"MM Gottardis","year":"1988","unstructured":"Gottardis MM, Robinson SP, Satyaswaroop PG, Jordan VC (1988) Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res 48:812\u2013815","journal-title":"Cancer Res"},{"key":"2198_CR20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1102\/1470-7330.2008.0020","volume":"8","author":"SA Polin","year":"2008","unstructured":"Polin SA, Ascher SM (2008) The effect of tamoxifen on the genital tract. Cancer Imaging 8:135\u2013145","journal-title":"Cancer Imaging"},{"key":"2198_CR21","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1200\/JCO.1999.17.5.1488","volume":"17","author":"JE Mortimer","year":"1999","unstructured":"Mortimer JE, Boucher L, Baty J, Knapp DL, Ryan E, Rowland JH (1999) Effect of tamoxifen on sexual functioning in patients with breast cancer. J Clin Oncol 17:1488\u20131492","journal-title":"J Clin Oncol"},{"key":"2198_CR22","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.bjc.6600294","volume":"86","author":"MJ Mourits","year":"2002","unstructured":"Mourits MJ, B\u00f6ckermann I, de Vries EG, van der Zee AG, ten Hoor KA, van der Graaf WT, Sluiter WJ, Willemse PH (2002) Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy. Br J Cancer 86:1546\u20131550","journal-title":"Br J Cancer"},{"key":"2198_CR23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0029-7844(00)01196-0","volume":"97","author":"MJ Mourits","year":"2001","unstructured":"Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG (2001) Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 97:855\u2013866","journal-title":"Obstet Gynecol"},{"key":"2198_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/713605341","volume":"6","author":"JE Dew","year":"2003","unstructured":"Dew JE, Wren BG, Eden JA (2003) A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer. Climacteric 6:45\u201352","journal-title":"Climacteric"},{"key":"2198_CR25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/713605234","volume":"5","author":"JE Dew","year":"2002","unstructured":"Dew JE, Wren BG, Eden JA (2002) Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study. Climacteric 5:151\u2013155","journal-title":"Climacteric"},{"key":"2198_CR26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/09513591003632258","volume":"26","author":"N Biglia","year":"2010","unstructured":"Biglia N, Peano E, Sgandurra P, Moggio G, Panuccio E, Migliardi M, Ravarino N, Ponzone R, Sismondi P (2010) Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Gynecol Endocrinol 26:404\u2013412","journal-title":"Gynecol Endocrinol"},{"key":"2198_CR27","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1470-2045(08)70259-6","volume":"9","author":"J Cuzick","year":"2008","unstructured":"Cuzick J, Sestak I, Cella D, Fallowfield L et al (2008) Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol 9:1143\u20131148","journal-title":"Lancet Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2198-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-012-2198-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2198-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T20:43:49Z","timestamp":1643229829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-012-2198-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,19]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["2198"],"URL":"https:\/\/doi.org\/10.1007\/s10549-012-2198-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,19]]}}}